Royalty Pharma plc RPRX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 544.86M | 836.99M | 608.30M | 637.50M | 955.04M |
| Total Receivables | 972.81M | 920.93M | 807.36M | 883.70M | 888.97M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.90M | 6.66M | 10.16M | 6.89M | 5.52M |
| Total Current Assets | 1.53B | 1.76B | 1.43B | 1.53B | 1.85B |
|
|
|||||
| Total Current Assets | 1.53B | 1.76B | 1.43B | 1.53B | 1.85B |
| Net Property, Plant & Equipment | -- | -- | 18.30M | 19.10M | 19.80M |
| Long-term Investments | 923.54M | 923.54M | 924.63M | 924.63M | 924.63M |
| Goodwill | 923.54M | 923.54M | 924.63M | 924.63M | 924.63M |
| Total Other Intangibles | -- | -- | -- | -- | 5.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.20B | 16.26B | 16.60B | 16.27B | 15.83B |
| Total Assets | 19.46B | 19.82B | 19.82B | 19.62B | 19.35B |
|
|
|||||
| Total Accounts Payable | 31.42M | 35.57M | 25.48M | 19.40M | 41.42M |
| Total Accrued Expenses | 19.69M | 107.77M | 25.30M | 110.82M | 29.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 996.97M | 380.00M | 383.19M | 383.16M | 383.12M |
| Total Finance Division Other Current Liabilities | 130.92M | 107.60M | 101.71M | 122.83M | 77.22M |
| Total Other Current Liabilities | 130.92M | 107.60M | 101.71M | 122.83M | 77.22M |
| Total Current Liabilities | 1.18B | 630.93M | 535.68M | 636.21M | 530.80M |
|
|
|||||
| Total Current Liabilities | 1.18B | 630.93M | 535.68M | 636.21M | 530.80M |
| Long-Term Debt | 7.59B | 8.58B | 8.58B | 8.57B | 8.57B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 15.30M | 16.10M | 16.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 896.43M | 821.24M | 751.16M | 682.61M | 612.98M |
| Total Liabilities | 9.67B | 10.03B | 9.88B | 9.91B | 9.73B |
|
|
|||||
| Common Stock & APIC | 4.34B | 4.38B | 4.38B | 4.12B | 4.11B |
| Retained Earnings | 2.50B | 2.46B | 2.51B | 2.36B | 2.30B |
| Treasury Stock & Other | -2.73M | -2.72M | -2.71M | -2.61M | -2.61M |
| Total Common Equity | 6.84B | 6.83B | 6.89B | 6.48B | 6.41B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.84B | 6.83B | 6.89B | 6.48B | 6.41B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.96B | 2.95B | 3.05B | 3.24B | 3.21B |
| Total Equity | 9.80B | 9.79B | 9.94B | 9.71B | 9.62B |
|
|
|||||